DNA testing could reunite families at the US border — and fuel surveillance
By Russell Brandom and Rachel Becker,
The Verge
| 06. 22. 2018
More than 2,000 children have been separated from their parents at the US border as a result of the White House’s new “zero tolerance” policy, and immigration agencies seem to have no clear plan for reuniting them. In one case, a six-year-old’s ability to remember her aunt’s phone number became her only lifeline to her family. “Most children here aren’t able to give names, much less a phone number,” an official told ProPublica. With children less than a year old lost in the system, it’s become heartbreakingly difficult to simply match children to the parents that brought them.
In the midst of the crisis, consumer DNA companies are offering their services as an unlikely solution. After a nudge from a member of Congress, 23andMe has offered to donate DNA kits and other resources, using spit samples to help parents find missing children in the bureaucratic maze. MyHeritage made a similar offer, promising that the tests will be processed within the company and not shared with third parties. “We’re calling upon relevant government agencies to help us with...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...